Assembly Biosciences (ASMB) Research & Development (2010 - 2026)

Assembly Biosciences' Research & Development history runs 17 years deep, the most recent figure standing at $14.9 million for Q1 2026.

• In Q1 2026, Research & Development changed 0.33% year-over-year to $14.9 million; the TTM figure through Mar 2026 stood at $64.9 million (up 10.11% YoY), while the FY2025 annual figure was $64.8 million, up 15.88% from the prior year.
• Research & Development was $14.9 million for Q1 2026 at Assembly Biosciences, down from $17.2 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $18.1 million in Q3 2022 to a low of $10.8 million in Q3 2023.
• Historically, Research & Development has averaged $15.0 million across 5 years, with a median of $14.9 million in 2026.
• The sharpest annual moves came in 2023 and 2024: Research & Development sank 40.3% in 2023, then climbed 29.83% in 2024.
• A 5-year view of Research & Development shows it stood at $16.9 million in 2022, then plunged by 34.69% to $11.0 million in 2023, then climbed by 29.75% to $14.3 million in 2024, then climbed by 20.8% to $17.2 million in 2025, then fell by 13.62% to $14.9 million in 2026.
• The last three Research & Development figures came in at $14.9 million (Q1 2026), $17.2 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.